Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 ( SGLT2 ) inhibitor, as add‐on to metformin in type 2 diabetes with mild hyperglycaemia
SGLT2 Inhibitors and Diuresis
Harnessing SGLT2 Inhibitors